Results for tag: "Aicardi Goutieres Syndrome Drugs"

Aicardi Goutieres Syndrome (AGS) is a rare genetic disorder that affects the central nervous system. It is characterized by a range of neurological symptoms, including seizures, developmental delays, and white matter abnormalities. Treatment for AGS is largely supportive, with medications used to manage symptoms. Central nervous system drugs are used to treat the neurological symptoms associated with AGS, such as seizures, spasticity, and cognitive impairment. These drugs include anticonvulsants, muscle relaxants, and antipsychotics. Additionally, medications may be used to treat the underlying cause of AGS, such as antiviral drugs and immunomodulators. Companies in the Aicardi Goutieres Syndrome Drugs market include AbbVie, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer, Inc., and Sanofi S.A. Show Less Read more